AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

The Relationship Between Upper Extremity Function and Balance and Functional Mobility in Parkinson's Disease

Recruitingn/aAges 18 Years - 80 YearsAllGazi University
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

Parkinson's Disease (PD) is the second most common neurodegenerative disease, affecting 2-3% of the population aged 65 and over, characterized by the loss of dopaminergic neurons. The basal ganglia play a significant role in the pathogenesis of PD. The lesions of the basal ganglia impair the ability of patients to perform complex, goal-oriented, and skill-requiring movements. Consequently, motor symptoms such as bradykinesia, rigidity, hypokinesia, and tremor, which are progressively worse, are added to the clinical picture of the disease. These symptoms, which cause movement and activity limitations in individuals with PD, also affect upper extremity functions, balance, and functional mobility. Impairment of upper extremity functions, commonly seen from the early stages of the disease, can affect many basic activities of daily living, including buttoning clothes, tying shoelaces, sewin

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Having accepted participation in the study after being provided with detailed information about the research * Having been diagnosed with only Parkinson's Disease by a specialist physician * Having a Standardized Mini-Mental Test score greater than 24 * Being in stages 1 to 3 according to the Hoehn and Yahr Scale Exclusion Criteria: * Having any vision, hearing, or perceptual issues that could affect the research outcomes * Having an orthopedic problem in the upper extremity that could impact hand dexterity, balance, or mobility * Having a cardiovascular, pulmonary, or hormonal disorder
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

1 site
Sivas Cumhuriyet University
Sivas, Turkey (Tรผrkiye)
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy